Welcome to LookChem.com Sign In|Join Free
  • or
5-FLUORO-1,3-DIHYDRO-2H-BENZIMIDAZOL-2-THIONE is a heterocyclic chemical compound with the molecular formula C8H6FNS, featuring fluorine and sulfur atoms in its structure. It is widely recognized for its diverse biological activities and potential therapeutic applications, particularly in pharmaceutical research and drug development.

583-42-6

Post Buying Request

583-42-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

583-42-6 Usage

Uses

Used in Pharmaceutical Research and Drug Development:
5-FLUORO-1,3-DIHYDRO-2H-BENZIMIDAZOL-2-THIONE is used as a key intermediate in the synthesis of various pharmaceutical compounds, particularly for the development of antifungal and antiviral medications. Its unique structure and properties contribute to the discovery of novel therapeutic agents with improved efficacy and safety profiles.
Used in Antifungal Applications:
In the Antifungal Industry, 5-FLUORO-1,3-DIHYDRO-2H-BENZIMIDAZOL-2-THIONE is used as an active ingredient in the formulation of antifungal drugs. It targets fungal pathogens by inhibiting essential cellular processes, thereby preventing their growth and proliferation, and providing effective treatment for various fungal infections.
Used in Antiviral Applications:
In the Antiviral Industry, 5-FLUORO-1,3-DIHYDRO-2H-BENZIMIDAZOL-2-THIONE is utilized as a potent antiviral agent, capable of inhibiting viral replication and assembly. Its incorporation into antiviral medications offers a promising approach to combat viral diseases and reduce the associated morbidity and mortality.
Used in Cancer Treatment:
In the Oncology Industry, 5-FLUORO-1,3-DIHYDRO-2H-BENZIMIDAZOL-2-THIONE is employed as a potential anticancer agent, exhibiting cytotoxic effects on cancer cells and modulating various signaling pathways involved in tumor growth and progression. Its use in cancer treatment may lead to the development of novel therapeutic strategies for various types of cancer.
Used in Autoimmune Disease Treatment:
In the Autoimmune Disease Industry, 5-FLUORO-1,3-DIHYDRO-2H-BENZIMIDAZOL-2-THIONE is used as a potential therapeutic agent for the treatment of autoimmune diseases. Its immunomodulatory properties may help regulate the immune system, reducing inflammation and preventing tissue damage in conditions such as rheumatoid arthritis, lupus, and multiple sclerosis.
Overall, the diverse applications of 5-FLUORO-1,3-DIHYDRO-2H-BENZIMIDAZOL-2-THIONE across various industries highlight its significance in the field of medicine and its potential to contribute to the development of innovative therapeutic solutions.

Check Digit Verification of cas no

The CAS Registry Mumber 583-42-6 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,8 and 3 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 583-42:
(5*5)+(4*8)+(3*3)+(2*4)+(1*2)=76
76 % 10 = 6
So 583-42-6 is a valid CAS Registry Number.

583-42-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-fluoro-1,3-dihydrobenzimidazole-2-thione

1.2 Other means of identification

Product number -
Other names 6-fluorobenzimidazole-2-thiol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:583-42-6 SDS

583-42-6Relevant academic research and scientific papers

ARYL HYDROCARBON RECEPTOR LIGANDS AND THEIR ANALOGUES FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISORDERS

-

Page/Page column 79-80, (2022/04/03)

Aryl hydrocarbon receptor (AHR) agonists and their use in treating or preventing or reducing the risk of an inflammatory disorder associated with a reduced expression of an aryl hydrocarbon receptor (AHR), including necrotizing enterocolitis, for preventing, reducing the risk of, or reducing the severity of an inflammatory disorder associated with a reduced expression of an aryl hydrocarbon receptor (AHR), and as an additive to infant nutritional formulas.

A new series of benzoxazole-based SIRT1 modulators for targeted therapy of non-small-cell lung cancer

Sever, Belgin,Akal?n ?ift?i, Gül?en,Alt?ntop, Mehlika Dilek

, (2020/09/21)

In an attempt to identify potential anticancer agents for non-small-cell lung cancer (NSCLC) targeting sirtuin 1 (SIRT1), the synthesis of a new series of benzoxazoles (3a – i) was carried out through a facile and versatile synthetic route. The compounds were evaluated for their cytotoxic effects on A549 human lung adenocarcinoma and NIH/3T3 mouse embryonic fibroblast cells using the MTT assay. 2-[(5-Nitro-1H-benzimidazol-2-yl)thio]-N-(2-methylbenzoxazol-5-yl)acetamide (3e) and 2-[(5-chloro-1H-benzimidazol-2-yl)thio]-N-(2-methylbenzoxazol-5-yl)acetamide (3g) were the most potent and selective anticancer agents in this series against the A549 cell line, with IC50 values of 46.66 ± 11.54 and 55.00 ± 5.00 μM, respectively. The flow cytometry-based apoptosis detection assay was performed to determine their effects on apoptosis in A549 cells. Both compounds induced apoptosis in a dose-dependent manner. The effects of compounds 3e and 3g on SIRT1 activity were determined. On the basis of in vitro studies, it was observed that compound 3g caused a significant decrease in SIRT1 levels in a dose-dependent manner, whereas compound 3e increased the SIRT1 levels. According to molecular docking studies, the substantial alteration in the type of action could be attributed to the difference between the interactions of compounds 3e and 3g with the same residues in the active site of SIRT1 (PDB code: 4IG9). On the basis of in silico ADME (absorption, distribution, metabolism, and excretion) studies, these compounds are predicted to possess favorable ADME profiles. According to the in vitro and in silico studies, compounds 3e and 3g, small-molecule SIRT1 modulators, were identified as potential orally bioavailable anticancer agents for the targeted therapy of NSCLC.

Highly Diastereoselective Synthesis of Dihydro-benzoimidazo-[1,3]-thiazines via Electro-oxidative Selenocyclization of Thioallyl Benzoimidazoles

Halder, Atreyee,Mahanty, Kingshuk,Maiti, Debabrata,De Sarkar, Suman

supporting information, p. 3895 - 3899 (2021/10/23)

The current methodology reveals a green and proficient electro-oxidative tandem selenocyclization of thioallyl benzoimidazoles manufacturing selenylated dihydro-benzoimidazo-thiazine derivatives. Both C?Se and C?N bond formation were achieved via this mild protocol which exhibits good functional group tolerability affording an extensive range of substrate scope up to 96% isolated yields. Complete control over the regioselective formation of the six-membered heterocycle and stereoselective construction of the contiguous stereocenters was established. The practical electrochemical method operates in an undivided cell at ambient temperature without using any metal and external chemical oxidant.

Three-Component Synthesis of 2-Alkylthiobenzoazoles in Aqueous Media

Chen, Jin-Quan,Dong, Zhi-Bing,Guo, Jia

, p. 1927 - 1933 (2020/07/03)

A highly efficient three-component protocol for the synthesis of the 2-alkylthiobenzoazoles is described. Tetramethylthiuram disulfide (TMTD) cyclized with o -aminothiophenols, generating the intermediate 2-mercaptobenzothiazoles, and the successive C-S coupling with halogenated alkanes afforded a series of 2-alkyl-substituted thiobenzothiazoles smoothly in a one-pot process. This procedure could also be utilized for the preparation of 2-alkyl-substituted thiobenzoxazoles and 2-alkyl-substituted thiobenzimidazoles. Inexpensive and easily available starting materials, metal catalyst-free, broad substrate scope, and water as solvent are the features of this protocol.

AlCl3-Promoted Synthesis of 2-Mercapto Benzoheterocycles by Using Sodium Dimethyldithiocarbamate as Thiocarbonyl Surrogate

Liu, Xing,Zhang, Shi-Bo,Dong, Zhi-Bing

, p. 5406 - 5411 (2018/10/20)

A simple, expeditious and high-efficiency synthetic method for the AlCl3-mediated one-pot preparation of 2-mercapto benzoheterocycles (2-mercapto benzothiazoles, benzoxazoles and benzimidazoles) is described. By the treatment of a series of S, O and N heteroatoms containing bifunctional molecules with sodium dimethyldithiocarbamate in AlCl3, the desired benzoheterocycles are obtained smoothly. The protocol can also be applied on the synthesis of a series of thiazolidine-2-thiones, imidazolidine-2-thiones. This novel synthetic approach has advantages such as ligand-free, high efficiency, short reaction time, readily available starting materials and simple experimental procedures.

An environmentally benign and efficient synthesis of substituted benzothiazole-2-thiols, benzoxazole-2-thiols, and benzimidazoline-2-thiones in water

Liu, Xing,Liu, Min,Xu, Wan,Zeng, Meng-Tian,Zhu, Hui,Chang, Cai-Zhu,Dong, Zhi-Bing

, p. 5591 - 5598 (2017/12/06)

An efficient and practical method for the one-step synthesis of benzothiazole-2-thiols, benzoxazole-2-thiols and benzimidazoline-2-thiones by cyclization of 2-aminothiophenols, 2-aminophenols, and 1,2-phenylenediamines with tetramethylthiuram disulfide (TMTD) in water was described. The features of this method include metal/ligand-free, excellent yield, short reaction time and broad substrate scope. The method provides a facile and convenient preparation of some potentially biologically active compounds.

Potent, Selective, and Cell Active Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor Developed by Structure-Based Virtual Screening and Hit Optimization

Mao, Ruifeng,Shao, Jingwei,Zhu, Kongkai,Zhang, Yuanyuan,Ding, Hong,Zhang, Chenhua,Shi, Zhe,Jiang, Hualiang,Sun, Dequn,Duan, Wenhu,Luo, Cheng

, p. 6289 - 6304 (2017/08/02)

PRMT5 plays important roles in diverse cellular processes and is upregulated in several human malignancies. Besides, PRMT5 has been validated as an anticancer target in mantle cell lymphoma. In this study, we found a potent and selective PRMT5 inhibitor by performing structure-based virtual screening and hit optimization. The identified compound 17 (IC50 = 0.33 μM) exhibited a broad selectivity against a panel of other methyltransferases. The direct binding of 17 to PRMT5 was validated by surface plasmon resonance experiments, with a Kd of 0.987 μM. Kinetic experiments indicated that 17 was a SAM competitive inhibitor other than the substrate. In addition, 17 showed selective antiproliferative effects against MV4-11 cells, and further studies indicated that the mechanism of cellular antitumor activity was due to the inhibition of PRMT5 mediated SmD3 methylation. 17 may represent a promising lead compound to understand more about PRMT5 and potentially assist the development of treatments for leukemia indications.

A Palladium Iodide-Catalyzed Cyclocarbonylation Approach to Thiadiazafluorenones

Veltri, Lucia,Paladino, Veronica,Plastina, Pierluigi,Gabriele, Bartolo

, p. 6106 - 6111 (2016/07/26)

The first example of an additive cyclocarbonylation process leading to 1-thia-4a,9-diazafluoren-4-ones is reported. This process is based on the reaction of readily available 2-(propynylthio)benzimidazoles with carbon monoxide carried out in EtOH at 100 °C under a 5/2 mixture of CO-CO2 at 70 atm in the presence of the PdI2/KI catalytic system. Experimental evidence suggests a mechanistic pathway involving N-palladation of the substrate followed by CO insertion, triple bond insertion, protonolysis, and isomerization.

SAR156497, an exquisitely selective inhibitor of Aurora kinases

Carry, Jean-Christophe,Clerc, Fran?ois,Minoux, Hervé,Schio, Laurent,Mauger, Jacques,Nair, Anil,Parmantier, Eric,Le Moigne, Ronan,Delorme, Cécile,Nicolas, Jean-Paul,Krick, Alain,Abécassis, Pierre-Yves,Crocq-Stuerga, Véronique,Pouzieux, Stéphanie,Delarbre, Laure,Maignan, Sébastien,Bertrand, Thomas,Bjergarde, Kirsten,Ma, Nina,Lachaud, Sylvette,Guizani, Houlfa,Lebel, Rémi,Doerflinger, Gilles,Monget, Sylvie,Perron, Sébastien,Gasse, Francis,Angouillant-Boniface, Odile,Filoche-Rommé, Bruno,Murer, Michel,Gontier, Sylvie,Prévost, Céline,Monteiro, Marie-Line,Combeau, Cécile

supporting information, p. 362 - 375 (2015/03/04)

The Aurora family of serine/threonine kinases is essential for mitosis. Their crucial role in cell cycle regulation and aberrant expression in a broad range of malignancies have been demonstrated and have prompted intensive search for small molecule Auror

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 583-42-6